Brain Tumor Care > Acoustic Neuroma

A trusted team approach for over 30 years

Each year we treat more than 160 patients with acoustic neuroma or neurofibromatosis (NF-2). By collaborating with major health systems throughout the region, we offer all available treatment options: surgery, radiosurgery, and watch-and-wait (observation), as well as balance and facial restoration treatments.

We discuss all acoustic neuroma cases with your hospital's multidisciplinary tumor board, a team of specialists that includes neurosurgeons, radiation oncologists, otologists, otolaryngologists, and physical medicine and rehabilitation specialists. Together, we share our opinions and then synthesize them into a recommended treatment strategy for you.

Advances in technology give Mayfield neurosurgeons unprecedented access to acoustic neuroma tumors, while allowing us to operate without harming delicate structures and cranial nerves. Radiation technologies like Gamma Knife allow us to treat some acoustic neuromas without making any incision at all. We seek to eliminate as much tumor as possible while preserving neurologic function, including hearing and the function of the facial nerve.

About acoustic neuromas

An acoustic neuroma is a tumor that grows from the nerves responsible for balance and hearing. These tumors grow from the sheath covering the vestibulocochlear nerve. Acoustic neuromas are benign (not cancer) and usually grow slowly. Over time the tumor can cause gradual hearing loss, ringing in the ear, and dizziness. Because of their slow growth, not all acoustic neuromas need to be treated. Treatment options include observation, surgery, and radiosurgery.

Learn more


In the past 5 years, Mayfield has seen 497 patients with acoustic neuromas and treated 149 new patients — making Mayfield a leading treatment program for these complex tumors.

The goals of treatment are to remove or halt the growth of the tumor while preserving facial nerve function and useful hearing (if not already deaf). Symptom resolution is highly dependent on tumor size and if it is touching the brainstem. Consistent with the literature,1.2 Mayfield's patients have 91% resolution of their symptoms and 94% have improved or full activity level.

  1. JAMA Otolaryngol. 2023;149(4):352–358.
  2. N Engl J Med. 2021 Apr 8;384(14):1335-1348.